Nutrition, Growth & Development Among Very Preterm Infants

See also
Status	Clinical Trial	Phase
Completed	`NCT00715000` - Oral Versus Intravenous Rehydration for Prevention of Dehydration in Premature Babies, During the First Days of Life.	Phase 4
Completed	`NCT00747240` - Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression	N/A
Completed	`NCT04929977` - m-Health System for Tracking Kangaroo Mother Care and Temperature in Southern India	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00715000 - Oral Versus Intravenous Rehydration for Prevention of Dehydration in Premature Babies, During the First Days of Life.

Phase 4

Completed

NCT00747240 - Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression

N/A

Completed

NCT04929977 - m-Health System for Tracking Kangaroo Mother Care and Temperature in Southern India

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01103219
Study type	Interventional
Source	University of Oslo
Contact
Status	Terminated
Phase	Phase 3
Start date	August 2010
Completion date	May 2017

Nutrition, Growth and Development Among Very Preterm Infants — PRENU

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms